SCHEMBL25344251

SCHEMBL25344251

CN(CCCNc1c([N+](=O)[O-])ccc(Cl)c1Br)C(=O)OC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 1/20 0.36
ALDH1A1 P00352 4/20 0.34
HSP90AA1 P07900 1/20 0.34
HPGD P15428 1/20 0.34
MAPT P10636 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HTT P42858 1/20 0.34
GPR55 Q9Y2T6 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM1 P11229 1/20 0.34
DRD2 P14416 1/20 0.34
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
CHRM3 P20309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5028697 0.86 MAPT (0.44) METAP2ALDH1A1MAPTLMNACYP3A4
SCHEMBL25346494 0.84 METAP2 (0.36) METAP2ALDH1A1HSP90AA1HPGDMAPT
SCHEMBL31376654 0.84 CHRM2 (0.41) METAP2ALDH1A1HPGDMAPTNPSR1
SCHEMBL25344580 0.83 METAP2 (0.38) METAP2CYP1A2DRD2FPR3FPR2
SCHEMBL25342692 0.82 MAPT (0.38) METAP2ALDH1A1HPGDMAPTNPSR1
SCHEMBL25344845 0.79 ALDH1A1 (0.46) METAP2ALDH1A1HPGDMAPTLMNA
SCHEMBL25344735 0.78 MEN1 (0.39) METAP2ALDH1A1MAPTHTTGAA
SCHEMBL25343679 0.78 ALDH1A1 (0.60) ALDH1A1MAPTNPSR1LMNACYP1A2
SCHEMBL25342497 0.77 METAP2 (0.38) METAP2CYP1A2FPR3FPR2
SCHEMBL25345810 0.76 METAP2 (0.36) METAP2MAPTCHRM2CHRM1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4472739-A1 IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2024-12-11 EP disclosed
WO-2023148129-A1 IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2023-08-10 WO disclosed